Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of bioactive molecules requiring high enantiomeric purity. Its structure supports the development of central nervous system agents and enzyme inhibitors. The tert-butyloxycarbonyl (Boc) protecting group facilitates stepwise synthesis by stabilizing the amine functionality during reactions, then can be easily removed under mild acidic conditions when needed. Commonly employed in asymmetric synthesis routes where the (R)-configuration is essential for biological activity.